Veliparib poly ADP-ribose polymerase (PARP) inhibitor

ABT-888 - ABT888 - ABT 888 - 2-(2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide - 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide

Advanced breast cancer (metastatic)

All type of patients:  1 trials  - NCT02163694

veliparib with carboplatin and caclitaxel vs Placebo with Carboplatin and Paclitaxel

No demonstrated result
See more clinical conditions

BRCA-mutated:  1 trials  - NCT02163694

veliparib with carboplatin and caclitaxel vs Placebo with Carboplatin and Paclitaxel

No demonstrated result



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons